Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-16-024408)

Filing Details

Accession Number:: 0001179110-16-024408
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-12 16:07:39
Reporting Period:: 2016-05-10

Filing Date:: 2016-05-12
Accepted Time:: 2016-05-12 16:07:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235007	Endocyte Inc	ECYT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509669	S Philip Low	3000 Kent Ave, Suite A1-100 West Lafayette IN 47906	Chief Science Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-05-10	11,566	$0.00	206,606	No	4	G	Direct
Common Stock	Acquisiton	2016-05-10	11,375	$3.52	217,981	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	G	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	193,318	Indirect	By spouse trust

Footnotes

Represents the purchase of 11,375 shares in multiple transactions, ranging in price from $3.46 to $3.56 per share, resulting in a weighted average purchase price per share of $3.52. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range.